Literature DB >> 24562547

DNA fragmentation and caspase-independent programmed cell death by modulated electrohyperthermia.

N Meggyeshazi1, G Andocs, L Balogh, P Balla, G Kiszner, I Teleki, A Jeney, T Krenacs.   

Abstract

BACKGROUND AND
PURPOSE: The electric field and the concomitant heat (electrohyperthermia) can synergistically induce cell death in tumor tissue, due to elevated glycolysis, ion concentration, and permittivity in malignant compared with nonmalignant tissues. Here we studied the mechanism and time course of tumor destruction caused by electrohyperthermia.
MATERIAL AND METHODS: Bilateral implants of HT29 colorectal cancer in the femoral regions of Balb/c (nu/nu) mice were treated with a single 30-min shot of modulated, 13.56-MHz, radiofrequency-generated electrohyperthermia (mEHT). Tumors at 0, 1, 4, 8, 14, 24, 48, and 72 h posttreatment were studied for morphology, DNA fragmentation, and cell death response-related protein expression using tissue microarrays, immunohistochemistry, Western immunoblots, and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assays.
RESULTS: Modulated EHT treatment induced significant tumor destruction in HT29 xenografts with a peak of a sevenfold increase compared with the untreated controls. The significant treatment-related elevation of DNA fragmentation--detected with TUNEL assay--and apoptotic bodies between 24 and 72 h posttreatment was proof of a programmed cell death response. This was associated with significant mitochondrial accumulation of bax and mitochondrial-to-cytoplasmic release of cytochrome c proteins between 8 and 14 h. Cleaved caspase-3 levels were low and mainly localized to inflammatory cells. The substantial cytoplasmic-to-nuclear translocation of apoptosis-inducing factor (AIF) and its 57-kDa activated fragment detected between 14 and 24 h after treatment indicated AIF as an effector for DNA fragmentation.
CONCLUSION: Modulated EHT treatment can induce programmed cell death-related tumor destruction in HT29 colorectal adenocarcinoma xenografts, which dominantly follows a caspase-independent subroutine.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24562547     DOI: 10.1007/s00066-014-0617-1

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  37 in total

1.  Apoptosis induced by hyperthermia in Dunn osteosarcoma cell line in vitro.

Authors:  Y Rong; P Mack
Journal:  Int J Hyperthermia       Date:  2000 Jan-Feb       Impact factor: 3.914

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 3.  Cell biological effects of hyperthermia alone or combined with radiation or drugs: a short introduction to newcomers in the field.

Authors:  Harm H Kampinga
Journal:  Int J Hyperthermia       Date:  2006-05       Impact factor: 3.914

Review 4.  Caspase-independent cell death.

Authors:  Guido Kroemer; Seamus J Martin
Journal:  Nat Med       Date:  2005-07       Impact factor: 53.440

5.  A phase II clinical study on relapsed malignant gliomas treated with electro-hyperthermia.

Authors:  Giammaria Fiorentini; Petros Giovanis; Susanna Rossi; Patrizia Dentico; Raffaele Paola; Gina Turrisi; Paolo Bernardeschi
Journal:  In Vivo       Date:  2006 Nov-Dec       Impact factor: 2.155

6.  Impedance spectra of tumour tissue in comparison with normal tissue; a possible clinical application for electrical impedance tomography.

Authors:  B Blad; B Baldetorp
Journal:  Physiol Meas       Date:  1996-11       Impact factor: 2.833

7.  Hyperthermia induces apoptosis in malignant fibrous histiocytoma cells in vitro.

Authors:  M Yonezawa; T Otsuka; N Matsui; H Tsuji; K H Kato; A Moriyama; T Kato
Journal:  Int J Cancer       Date:  1996-05-03       Impact factor: 7.396

Review 8.  The Warburg effect in 2012.

Authors:  Jean-Pierre Bayley; Peter Devilee
Journal:  Curr Opin Oncol       Date:  2012-01       Impact factor: 3.645

9.  Interaction of the 2,6-dimethoxysemiquinone and ascorbyl free radicals with Ehrlich ascites cells: a probe of cell-surface charge.

Authors:  R Pethig; P R Gascoyne; J A McLaughlin; A Szent-Györgyi
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

10.  Recombinant human erythropoietin alpha improves the efficacy of radiotherapy of a human tumor xenograft, affecting tumor cells and microvessels.

Authors:  József Lövey; Bíborka Bereczky; Réka Gilly; István Kenessey; Erzsébet Rásó; Erika Simon; Judit Dobos; Agnes Vágó; Miklós Kásler; Balázs Döme; József Tímár; József Tóvári
Journal:  Strahlenther Onkol       Date:  2008-01       Impact factor: 3.621

View more
  28 in total

Review 1.  Nanoparticles and nanothermia for malignant brain tumors, a suggestion of treatment for further investigations.

Authors:  Cristina Prieto; Isabel Linares
Journal:  Rep Pract Oncol Radiother       Date:  2018-09-06

2.  Local modulated electro-hyperthermia in combination with traditional Chinese medicine vs. intraperitoneal chemoinfusion for the treatment of peritoneal carcinomatosis with malignant ascites: A phase II randomized trial.

Authors:  Clifford L K Pang; Xinting Zhang; Zhen Wang; Junwen Ou; Yimin Lu; Pengfei Chen; Changlin Zhao; Xiaopu Wang; Hongyu Zhang; Sergey V Roussakow
Journal:  Mol Clin Oncol       Date:  2017-04-10

3.  Upregulation of heat shock proteins and the promotion of damage-associated molecular pattern signals in a colorectal cancer model by modulated electrohyperthermia.

Authors:  Gabor Andocs; Nora Meggyeshazi; Lajos Balogh; Sandor Spisak; Mate Elod Maros; Peter Balla; Gergo Kiszner; Ivett Teleki; Csaba Kovago; Tibor Krenacs
Journal:  Cell Stress Chaperones       Date:  2014-06-29       Impact factor: 3.667

Review 4.  Current status of oncothermia therapy for lung cancer.

Authors:  Andras Szasz
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2014-04-10

5.  Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy.

Authors:  Yuk-Wah Tsang; Cheng-Chung Huang; Kai-Lin Yang; Mau-Shin Chi; Hsin-Chien Chiang; Yu-Shan Wang; Gabor Andocs; Andras Szasz; Wen-Tyng Li; Kwan-Hwa Chi
Journal:  BMC Cancer       Date:  2015-10-15       Impact factor: 4.430

6.  Comparison of biological effects of modulated electro-hyperthermia and conventional heat treatment in human lymphoma U937 cells.

Authors:  G Andocs; M U Rehman; Q-L Zhao; Y Tabuchi; M Kanamori; T Kondo
Journal:  Cell Death Discov       Date:  2016-06-13

7.  Modulated electro-hyperthermia induced loco-regional and systemic tumor destruction in colorectal cancer allografts.

Authors:  Tamas Vancsik; Csaba Kovago; Eva Kiss; Edina Papp; Gertrud Forika; Zoltan Benyo; Nora Meggyeshazi; Tibor Krenacs
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

8.  Olesoxime Inhibits Cardioplegia-Induced Ischemia/Reperfusion Injury. A Study in Langendorff-Perfused Rabbit Hearts.

Authors:  Aida Salameh; Maren Keller; Ingo Dähnert; Stefan Dhein
Journal:  Front Physiol       Date:  2017-05-19       Impact factor: 4.566

9.  Cytotoxic T cells response with decreased CD4/CD8 ratio during mammary tumors inhibition in rats induced by non-contact electric fields.

Authors:  Firman Alamsyah; Rarastoeti Pratiwi; Nisrina Firdausi; Jessica Irene Mesak Pello; Subekti Evi Dwi Nugraheni; Ahmad Ghitha Fadhlurrahman; Luthfi Nurhidayat; Warsito Purwo Taruno
Journal:  F1000Res       Date:  2021-01-19

10.  Clinical and economic evaluation of modulated electrohyperthermia concurrent to dose-dense temozolomide 21/28 days regimen in the treatment of recurrent glioblastoma: a retrospective analysis of a two-centre German cohort trial with systematic comparison and effect-to-treatment analysis.

Authors:  Sergey V Roussakow
Journal:  BMJ Open       Date:  2017-11-03       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.